Ghattas, M.; Dwivedi, G.; Chevrier, A.; Scobey, T.; El-Mayta, R.; Mattocks, M.D.; Wang, D.; Lavertu, M.; Alameh, M.-G.
Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy. Vaccines 2025, 13, 788.
https://doi.org/10.3390/vaccines13080788
AMA Style
Ghattas M, Dwivedi G, Chevrier A, Scobey T, El-Mayta R, Mattocks MD, Wang D, Lavertu M, Alameh M-G.
Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy. Vaccines. 2025; 13(8):788.
https://doi.org/10.3390/vaccines13080788
Chicago/Turabian Style
Ghattas, Majed, Garima Dwivedi, Anik Chevrier, Trevor Scobey, Rakan El-Mayta, Melissa D. Mattocks, Dong Wang, Marc Lavertu, and Mohamad-Gabriel Alameh.
2025. "Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy" Vaccines 13, no. 8: 788.
https://doi.org/10.3390/vaccines13080788
APA Style
Ghattas, M., Dwivedi, G., Chevrier, A., Scobey, T., El-Mayta, R., Mattocks, M. D., Wang, D., Lavertu, M., & Alameh, M.-G.
(2025). Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy. Vaccines, 13(8), 788.
https://doi.org/10.3390/vaccines13080788
